Burke & Herbert Financial Services Corp. (BHRB)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Burke & Herbert Financial Services Corp..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 73.30 $ — 96% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
8 of 10 Growth gemTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 56.8% passed
- More than 10% revenue growth is expected for the coming year 12.5% passed
- Share count grows by less than 3% a year 26.3% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 43.3% passed
- Gross margin at 40% or higher and without meaningful erosion 69.3% passed
- Goodwill from acquisitions does not grow faster than revenue 0.4% passed
- Net debt below twice EBITDA 1,132 m net cash passed
- Operating cash flow covers the profits of the last three years 61 m passed
- Return on capital at 15% or higher, or up versus two years ago 1.9% failed
- Insiders hold at least 10% or are net buyers 14.9% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 9.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6.84 | 6.37 – 7.92 | 439 | 3.3% | 4 |
| 12/31/2027 | 8.75 | 8.70 – 8.86 | 494 | 9.8% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 2.03 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.32 | 96.40 | 123 | 190.10 | 16.20 | 77 | 77 |
| 2025: Q1 | 1.81 | 161.40 | 120 | 181.90 | 22.70 | 38 | 36 |
| 2025: Q2 | 1.99 | – | 123 | 18.10 | 24.20 | 0 | -3 |
| 2025: Q3 | 1.98 | 8.00 | 122 | -4.60 | 24.60 | 39 | 35 |
| 2025: Q4 | 2.01 | 52.90 | 123 | 0.20 | 24.60 | 31 | 28 |
| 2026: Q1 | 1.81 | -0.20 | 118 | -1.10 | 23.10 | 27 | 25 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 113 | 32 | 27 | 3.55 | 35 | 329 | 2,960 |
| 2017 | 123 | 35 | 28 | 3.64 | 35 | 344 | 3,089 |
| 2018 | 130 | 38 | 34 | 4.54 | 35 | 346 | 3,007 |
| 2019 | 128 | 17 | 17 | 2.12 | 26 | 354 | 2,866 |
| 2020 | 121 | 28 | 27 | 3.31 | 23 | 385 | 3,425 |
| 2021 | 119 | 40 | 36 | 4.52 | 55 | 390 | 3,622 |
| 2022 | 127 | 52 | 44 | 5.89 | 61 | 273 | 3,563 |
| 2023 | 162 | 25 | 23 | 3.05 | 43 | 315 | 3,618 |
| 2024 | 397 | 40 | 36 | 2.39 | 86 | 730 | 7,812 |
| 2025 | 491 | 145 | 117 | 7.81 | 108 | 855 | 7,921 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Burke & Herbert Financial Services Corp. ist die Bankholding der Burke & Herbert Bank & Trust Company, die verschiedene kommunale Bankprodukte und -dienstleistungen in den USA anbietet.
| Employees | 1,100 |
|---|---|
| Headquarters | Alexandria, VA |
| Address | 100 S. Fairfax Street, 22314 Alexandria, United States |
| Phone | 703 666 3555 |
| Website | burkeandherbertbank.com |
| IPO Date | 15. Mar 2001 |
| ISIN | US12135Y1082 |
| Stock Split | 40:1 on 11/15/2022 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Roy E. Halyama | President | 1968 |
| Robert S. Tissue CPA | Executive VP & Head of Balance Sheet Strategy | 1963 |
| Kirtan Parikh | Executive VP & CFO | 1982 |
| Carl D. Lundblad Esq., J.D. | Executive VP & COO | 1971 |
| Patrick Kip Huffman CPA | Senior VP & Chief Accounting Officer | 1985 |
| Danyl R. Freeman | Executive VP & Chief Human Resources Officer | 1970 |
| Joseph F. Collum | Executive VP & Director of Business Banking | 1972 |
| Shannon Barrow Rowan | Executive VP and Director of Trust & Wealth Management | 1966 |
| Jennifer P. Schmidt | Executive VP & Chief Risk Officer | 1970 |
| Debra L. Mills | Principal Vice President of Business Systems Planning | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Freeman Danyl R | Chief Human Resources Officer | Other | 2,002 | 74.08 | 148,308 |
| 29. Jul 2026 | Freeman Danyl R | Chief Human Resources Officer | Other | 2,836 | 43.33 | 122,884 |
| 28. Jul 2026 | Boyle David P | Chair & CEO | Other | 1,752 | 0.00 | – |
| 17. Jul 2026 | Tissue Robert S | EVP, Financial Strategy | Other | 9,777 | 72.85 | 712,254 |
| 17. Jul 2026 | Tissue Robert S | EVP, Financial Strategy | Other | 4,110 | 51.58 | 211,994 |
| 17. Jul 2026 | Tissue Robert S | EVP, Financial Strategy | Other | 8,599 | 47.47 | 408,195 |
| 16. Jul 2026 | Ritchie Bradford E | EVP, Chief Lending Officer | Other | 2,222 | 70.76 | 157,229 |
| 16. Jul 2026 | Ritchie Bradford E | EVP, Chief Lending Officer | Other | 2,749 | 51.58 | 141,793 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.